Paul Hebeisen
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
- Organic Chemistry top 5%
- Synthesis and Biological Evaluation 6
- Quinazolinone synthesis and applications 5
- Synthesis and Catalytic Reactions 4
- Synthetic Organic Chemistry Methods 3
- Toxicology top 5%
- Pharmacology top 10%
-
- PI3K/AKT/mTOR signaling in cancer 10
- Cancer therapeutics and mechanisms 5
- Biochemical and Molecular Research 3
Paul Hebeisen
39 papers receiving 931 citations
Peers
Comparison fields: 5 of 76
- Molecular Medicine 157
- Organic Chemistry 402
- Toxicology 39
- Applied Microbiology and Biotechnology 19
- Pharmacology 158
Countries citing papers authored by Paul Hebeisen
This map shows the geographic impact of Paul Hebeisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hebeisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hebeisen more than expected).
Fields of papers citing papers by Paul Hebeisen
This network shows the impact of papers produced by Paul Hebeisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hebeisen. The network helps show where Paul Hebeisen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Hebeisen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 8 | |
| 4 | 2020 | 18 | |
| 5 | 2019 | 30 | |
| 6 | 2019 | 7 | |
| 7 | 2019 | 49 | |
| 8 | 2017 | 8 | |
| 9 | 2017 | 115 | |
| 10 | 2011 | 14 | |
| 11 | 2011 | 17 | |
| 12 | 2009 | 15 | |
| 13 | 2009 | 25 | |
| 14 | 2008 | 30 | |
| 15 | 2004 | 18 | |
| 16 | 2003 | 1 | |
| 17 | 2002 | 13 | |
| 18 | 1993 | 42 | |
| 19 | 1988 | 11 | |
| 20 | 1985 | 8 |
About Paul Hebeisen
Paul Hebeisen is a scholar working on Organic Chemistry, Molecular Medicine and Toxicology, having authored 39 papers that have together received 968 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Synthesis and Biological Evaluation (6 papers), Cancer therapeutics and mechanisms (5 papers), Quinazolinone synthesis and applications (5 papers), Synthesis and Catalytic Reactions (4 papers), Biochemical and Molecular Research (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Synthetic Organic Chemistry Methods (3 papers). The work is most often cited by research in Molecular Medicine (157 citations), Organic Chemistry (402 citations) and Toxicology (39 citations). Paul Hebeisen has collaborated with scholars based in Switzerland, Austria and Germany. Frequent co-authors include Peter Angehrn, Rudolf Then, Malcolm G. P. Page, Ingrid Heinze‐Krauss, P. Hohl, Matthias P. Wymann, Florent Beaufils, Chiara Borsari, Denise Rageot and Thomas Bohnacker. Their work appears in journals such as Journal of the American Chemical Society, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.